High-Mobility Group Box 1: Biomarker and Therapy in Neonatal Encephalopathy
In the intricate landscape of neonatal medicine, the pursuit of reliable biomarkers capable of predicting outcomes and guiding therapeutic interventions remains paramount. Neonatal encephalopathy (NE),...















